The ARRIVE trial demonstrated which finding regarding elective labour induction at 39 weeks in low-risk nulliparous women?

• A Elective induction at 39 weeks increased cesarean delivery rates
• B Induction at 39 weeks increased NICU admissions
• C Expectant management to 41 weeks was associated with lower perinatal mortality
• D Elective induction at 39 weeks reduced cesarean delivery rates without worsening neonatal outcomes ✓

Explanation

The ARRIVE Trial (A Randomized Trial of Induction Versus Expectant Management, NEJM 2018) showed that elective induction at 39 weeks in low-risk nulliparous women did not increase — and actually slightly reduced — cesarean delivery rates compared to expectant management, while neonatal outcomes were similar. This was counterintuitive and shifted practice. NICU admissions were similar or slightly lower in the induction group.

Reference: Williams Obstetrics, 26th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.